ClinTrialFinder: AI-Powered Cancer Clinical Trial Matching

ClinTrialFinder addresses a critical need in cancer care: efficient and informed clinical trial matching. The platform leverages AI to analyze data from ClinicalTrials.gov, ranking trials based on suitability scores derived from eligibility criteria and supporting medical evidence. This approach contrasts with traditional methods that often require patients and physicians to manually sift through hundreds of trials, a time-consuming and potentially overwhelming process.

The key innovation lies in the application of AI to provide evidence summaries and plain-language explanations, making complex medical information accessible to a broader audience. By filtering trials for relevance and presenting them in an easily understandable format, ClinTrialFinder empowers patients to make more informed decisions about their treatment options.

However, the tool's effectiveness is contingent on the quality and completeness of the data in ClinicalTrials.gov, as well as the accuracy of the AI algorithms. Biases in the data or limitations in the AI's ability to interpret medical literature could lead to suboptimal recommendations. Continuous monitoring and refinement of the AI are essential to ensure its reliability and validity. Transparency is ensured through adherence to the EU AI Act, specifically Article 50, by providing clear information about the tool's purpose, capabilities, and limitations, as well as the data sources and algorithms used.